Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation

Reproductive Biology and Endocrinology

Volumn 7, Issue , 2009, Pages

  Drakakis, Peter ^a   Loutradis, Dimitris ^a   Beloukas, Apostolos ^a   Sypsa, Vana ^a   Anastasiadou, Vasiliki ^a   Kalofolias, George ^a   Arabatzi, Helen ^a   Kiapekou, Erasmia ^a   Stefanidis, Konstantinos ^a   Paraskevis, Dimitris ^a   Makrigiannakis, Antonis ^b   Hatzakis, Angelos ^a   Antsaklis, Aris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b IVF Unit   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; COMPLEMENTARY DNA; FOLLITROPIN; LUTEINIZING HORMONE RECEPTOR; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFICACY; FEMALE; FERTILIZATION IN VITRO; HUMAN; LOW DRUG DOSE; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE; OOCYTE CLEAVAGE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY FOLLICLE CELL; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; BLOOD; CHEMISTRY; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE INFERTILITY; GENE DOSAGE; GENETICS; LYMPHOCYTE; METABOLISM; METHODOLOGY; PILOT STUDY; PREGNANCY; PROGNOSIS; TIME; TREATMENT OUTCOME;

ADULT; CHORIONIC GONADOTROPIN; DNA, COMPLEMENTARY; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GENE DOSAGE; HUMANS; INFERTILITY, FEMALE; LYMPHOCYTES; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PROGNOSIS; RECEPTORS, LH; RECOMBINANT PROTEINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 71149116589     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-7-110     Document Type: Article

References (24)

1. Shoham Z, Schacter M, Loumaye E, Weissman A, MacNamee M, Insler V. The luteinizing hormone surge--the final stage in ovulation induction: modern aspects of ovulation triggering. Fertil Steril 1995, 64:237-251.
2. Chandrasekher YA, Hutchison JS, Zelinski-Wooten MB, Hess DL, Wolf DP, Stouffer RL. Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge. J Clin Endocrinol Metab 1994, 79:298-306. 10.1210/jc.79.1.298, 8027245.
3. Yen SSC, Llenera G, Little B, Casper RF. Disappearance rate of endogenous luteinizing hormone and chorionic gonadotropin in man. J Clin Endocrinol Metab 1968, 28:1763-1767. 10.1210/jcem-28-12-1763, 5699949.
4. Weissman A, Lurie S, Zalel Y, Goldchmit R, Shoham Z. Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration. Gynecol Endocrinol 1996, 10:273-276. 10.3109/09513599609012319, 8908528.
5. Filicori M, Fazleabas AT, Huhtaniemi I, Licht P, Rao C, Tesarik J, Zygmunt M. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertil Steril 2005, 84:275-284. 10.1016/j.fertnstert.2005.02.033, 16084861.
6. Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM, Hugues JN, Lass A, Lyall H, Rasmussen P, Thong J, Traynor I, Westergaard L, Yates R, . Luveris Pretreatment Group Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum Reprod 2008, 23(2):421-6. Epub 2007 Dec 15, 10.1093/humrep/dem388, 18084048.
7. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985, 43:351-2.
8. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 2005, 84:394-401. 10.1016/j.fertnstert.2005.02.036, 16084880.
9. Loutradis D, Drakakis P, Kallianidis K, Bletsa R, Milingos S, Makris N, Michalas S. The effect of the duration of GnRH-agonist down regulation before ovarian stimulation on the biological and clinical outcome after intracytoplasmic sperm injection. Eur J Obstet Gynecol Reprod Biol 1998, 80:251-255. 10.1016/S0301-2115(98)00125-0, 9846679.
10. Patsoula E, Loutradis D, Drakakis P, Michalas L, Bletsa R, Michalas S. Messenger RNA expression for the follicle-stimulating hormone receptor and luteinizing hormone receptor in human oocytes and preimplantation-stage embryos. Fertil Steril 2003, 79:1187-1193. 10.1016/S0015-0282(03)00071-2, 12738515.
11. Patsoula E, Loutradis D, Drakakis P, Kallianidis K, Bletsa R, Michalas S. Expression of mRNA for the LH and FSH receptors in mouse oocytes and preimplantation embryos. Reproduction 2001, 121:455-461. 10.1530/rep.0.1210455, 11226072.
12. Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventivemeasures. Hum Reprod Update 2003, 9(3):275-89. 10.1093/humupd/dmg018, 12859048.
13. Rao CV. Multiple novel roles of luteinising hormone. Fertil Steril 2001, 76:1097-1100. 10.1016/S0015-0282(01)02863-1, 11730733.
14. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT. Luteinizing hormone activity supplementation enhances follicle stimulating hormone efficiency and improves ovulation induction outcome. J Clin Endocrinol Metab 1999, 84:2659-2663. 10.1210/jc.84.8.2659, 10443656.
15. Nyboe Andersen A, Humaidan P, Fried G. T.H.E. Nordic rLH study group. Addition of rLH (Luveris) to rFSH during the final days of follicular maturation in IVF/ICSI treated patients. A Nordic randomized multicenter trial. Hum Reprod, Abstract Book, 22nd Annual Meeting of the ESHRE, Prague, Czech Republic 2006, Abstract No 0-138.
16. Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008, 89(3):546-53. 10.1016/j.fertnstert.2007.03.088, 17531989.
17. Drakakis P, Loutradis D, Kallianidis K, Liapi A, Milingos S, Makrigiannakis A, Dionyssiou-Asteriou A, Michalas S. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET. Eur J Obstet Gynecol Reprod Biol 2005, 121:77-80. 10.1016/j.ejogrb.2004.12.021, 15989987.
18. Zeleznik AJ, Hillier SG. The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol 1984, 27:927-40. 10.1097/00003081-198412000-00014, 6098403.
19. Hillier SG, Whitelaw PF, Smyth CD, Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Mol Cell Endocrinol 1994, 100:51-54. 10.1016/0303-7207(94)90278-X, 8056158.
20. Emperaire JC, Edwards RG. Time to revolutionize the triggering of ovulation. Reprod Biomed Online 2005, 9:80-83.
21. Emperaire JC, Parneix I, Ruffied A. Luteal phase defects following agonist-triggered ovulation: a patient-dependant response. Reprod Biomed Online 2004, 9:22-27.
22. Funaro A, Sapino A, Ferranti B, Horenstein AL, Castellano I, Bagni B, Garotta G, Malavasi F. Functional, structural, and distribution analysis of the chorionic gonadotropin receptor using murine monoclonal antibodies. J Clin Endocrinol Metab 2003, 88:5537-5546. 10.1210/jc.2003-030977, 14602802.
23. Menon KM, Munshi UM, Clouser CL, Nair AK. Regulation of luteinizing hormone/human chorionic gonadotropin receptor expression; A perspective. Biol Reprod 2004, 70:861-866. 10.1095/biolreprod.103.024471, 14668203.
24. Minegishi T, Tano M, Abe Y, Nakamura K, Ibuki Y, Miyamoto K. Expression of luteinizing hormone/human chorionic gonadotrophin (LH/HCG) receptor mRNA in the human ovary. Mol Hum Reprod 1997, 3(2):101-107. 10.1093/molehr/3.2.101, 9239715.